BOLT
Bolt Biotherapeutics
$3.97
+$0.14 (+3.76%)Jul 27, 2026
Key metrics
The numbers that frame BOLT today
- Market cap
- $7.64M
- P/E (TTM)
- -0.3
- EV / FCF
- -0.5
- Gross margin
- 100%
- EV / Sales
- 2.8
- ROIC
- -47.8%
- Div yield
- 0%
- Debt / equity
- 1.1
- 52wk Low
- $3.75
- 52wk High
- $7.20
Growth
Revenue and earnings trend for BOLT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BOLT
Is Bolt Biotherapeutics a good buy?
No. Bolt Biotherapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Bolt Biotherapeutics is selling at a very high price.
What is the market capitalization of BOLT?
Bolt Biotherapeutics's market capitalization is $7.64M.
What is the P/E ratio for BOLT stock?
Bolt Biotherapeutics's current P/E ratio is -0.3.
What is the 52-week high for BOLT stock?
The 52-week high for Bolt Biotherapeutics is $7.20. The current close of $3.97 is 44.8% below that high.
What is the 52-week low for BOLT stock?
The 52-week low for Bolt Biotherapeutics is $3.75. The current close of $3.97 is 6% above that low.
Does BOLT stock pay dividends?
Bolt Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BOLT?
Bolt Biotherapeutics's Debt / Equity ratio is 1.13.